Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This stock could get to $.50 today easily. The near term perception could change to the point where everyone won't sell in the high $.40's because the risk-to-reward chart moves to more reward with each passing event. This isn't a single dimension, "We're going to sell MJ" type of business model.
There aren't many new industries being formulated. The lawmakers are clamoring for more revenue. They can't stop spending and this has mega-tax revenue WITH a high compasion component. Some of these pioneer companies will be part of an MA too. Too much upside potential, with money seeking growth investments.
And these points are separate from the PLab license. Just a tremedous amount of money sitting on the sidelines looking for a home in the 2nd half of this year. It's all upside. And I haven't started to talk about the levels of momentum that can further affect the value. IMO
This stock goes back to over $.70 with PhytaLAB certification/license news. I base my estimates on the psychology of previous values and from the prevailing expectations of this marketplace. There's pent up anticipation and broad appeal for a legitimate strong business model to be established.
Further, if any division or partner gets an MMPR license then this stock goes north of $1.50. Probably closer to $2.00 again. The PLab news is worth 30%-40% from where we sit today. That's a good years worth of gains in any book, let alone any other progress regarding partnerships/alliances/changes in state laws between now and the end of year. IMO.
Did you submit your buy order as "all or nothing?" Sometimes your amount of shares won't match with what's being offered at the Ask price. Just fyi.
Thank you for providing the link. After watching and listening, it's clear to me that Dr. Sexton is THE subject matter expert. She's the most knowledgable, most articulate, provides the most scientific detail and….. is an important part of our business model. This is not hype. This is proof of concept and substantial. IMO.
It would only take a few more brokerage houses to cover this company and things would get interesting real fast. Not to mention that the calendar is on our side as we move into the fall. As an investment, this company has very high upside potential and as the video shows - reduced risk as each month passes.
With reference to the article posted earlier today; I found it very interesting that the research company lumped TITAN in with all of the other med device/robot manufacturers by stating that "these were the key players globally."
"The key players in the global medical robots market are Intuitive Surgical, Inc. (U.S.), Accuray, Inc. (U.S.), MAKO Surgical Corp. (U.S.), Mazor Robotics Ltd. (Israel), Hansen Medical, Inc. (U.S.), Titan Medical, Inc. (Canada), and Health Robotics S.R.L. (Italy), among others."
Semi validation of sorts and welcome recognition. I think some of the increase pps today is because there are newly informed investors recognizing how much of a gift these shares are at this range. IMO
With reference to the article posted earlier today; I found it very interesting that the research company lumped TITAN in with all of the other med device/robot manufacturers by stating that "these were the key players globally."
"The key players in the global medical robots market are Intuitive Surgical, Inc. (U.S.), Accuray, Inc. (U.S.), MAKO Surgical Corp. (U.S.), Mazor Robotics Ltd. (Israel), Hansen Medical, Inc. (U.S.), Titan Medical, Inc. (Canada), and Health Robotics S.R.L. (Italy), among others."
Semi validation of sorts and welcome recognition. I think some of the increase pps today is because there are newly informed investors recognizing how much of a gift these shares are at this range. IMO
Looks like there was a sale of 2,500 shares at $.4175 near the time you submitted. Then a buyer came in at over $.43 for a 1,000 shares, then another buyer bought 5,000 shares at a little over $.43. Looks like by the time your bid hit, there was a buyer at $.43 which jumped yours.
Catching up today. Looks like there's another interested group of investors. Wonder if they're aware of Zack's coverage with a value of $1.00 ps? Noticed the volume this past week too. GLTA.
Dont think they could put that on the web site if they didn't already have the certification/license. No?
If you go to the website, then look under the ABOUT tab, then to the last column labeled PRICING. It states that "PhytaLAB is a membership service providing STATE certified testing."
Nice try Stan. Once news came out last week regarding Dr. Sexton's phone conversation confirming the pending WA license, and subsequent contracts with large customers for PhytaLAB - the share price has been solidified and making moves higher. Please also recall that Dr. Sexton mentioned in the same converstation to have a conference call in the near future to discuss the company business. I don't see $.20s or $.30's for that matter. IMO
After I read the resume, I think that there were opportunities available and she decided to compete. Others interviewed, she was picked. She attended college on a full ride athletic scholarship. It all fits. And for the speculation regarding (if it's really her as the consultant) overseas business - it should have been kept a secret just as many other aspects of the business and product development have in the past. Why disclose (again, if it was her) this regardless of who it was to the general public/competition? It would only serve to confirm progress to measured against the timeline. The timeline is an important tool from which the competition is weighing and measuring their progress too. IMO
We're way over sold at this price. Just compare where the company was - to the share price, over the course of the calendar year. And of course by comparing the business models based on all of the vertical elements of the other companies in the industry. Many are one demensional, or not well diversified. IMO
I can't dig up the coffee cans of cash from my backyard fast enough to buy more shares.
I appreciate your updates from the field and your opinions based on experience. Thank you. This is very important information to me. More positive news for SPORT. IMO
As an investor of this company, I ask this question. Who wants to be on the sidelines when Dr. Sexton speaks to the 420i group?
My experience tells me the following; She's not going to answer softball questions, or present specutlative information. The only purpose for her to invest her time would be to clarify subject matter that is pertinent to the progress and going concern of Phytalab.
Phytalab is generating revenue. Who wants to be on the sidelines when those numbers come out?
The 3 stooges can continue to pose their wisdom concerning the validity of this company, but I'm buying.
I see the dots, and connecting the dots.
Anyone have a date and time for that conference call with Dr. Sexton? Thank you.
Who in their right mind would only work for 100% commission? The "best" compensation plan is a base salary with incentive(s) and options set at higher strike prices. IMO
I think the June 16th and 30th announcements say it all. All objectives for Q2 successful and complete. Further it was easy to raise more capital necessary for further development. That's significant in my ongoing eval of the product and company.
What we know is confirmed.
We know that Ximedica (sp) has increased the manpower and technical engineering resources to continue further development to meet the next milestones. That to me is very - very important and positive, because that's the next level. More concentrated effort/resources are required as a product is moved through the progression from design, revision, development, and Gen1 final product freeze before further testing, certification and production. I see the dots and the connections.
The "PR" firm hasn't disclosed any new business developments. That's nothing new, different or bad. However it's always a possibility anytime in the future. Regardless of the numerous requests for further company updates, as has been pointed out repeatedly - the company must/will keep details secret to as to keep the competition from gettting any competitive information. This is very positive.
It's a sophisticated machine. Steady as she goes. No bad news is good news. More news would be better, but we do get updates as shown in June.
Occassionally we get the wayward ISRG knucklehead posting on the site - which to me further validates the progress and initial targeted functionality. a.k.a. fear and respect for the design.
We get broad and timely updates regarding the marketplace from an array of medical professionals, some of whom will/could be end users of the device. The industry professionals who contribute their comments regarding their daily experiences and summary conversations carry a lot of weight and further validate my initial decisions to invest. They also contribute significantly to the fear and respect factors.
Please continue with the professional contributions. Thank you.
If you look closely at the volume of trading, the amounts that are creating the downward trend(s) are very, very small transactions. The price is just getting pounded on in small amounts to portend a decline is coming. IMO, those that have made money and would like to get in at a lower price don't understand what a good business model looks like in an ever expanding market. Some of our posers (I mean posters) would prefer to create a short term trend than invest. There's a difference. IMO HTH
Volume has dried up significantly because the conviction at this price is very strong. We've only seen 15% of average daily volume. Hmmm….
It feels like the brakes are slowly being applied to this skid in pricing. The sector has already corrected, and I think we're closer to good news.
initially (if I were doing the support plan) the actual engineers will go into the field for the first run of units and accompany and train other field engineers. However the support structure is designed. There are 10's of thousands of field engineers that maintain large computer systems, and field robots around the world. One of the most important elements is the sophistacation of the diagnostics that have the most effect on field maintenance. Also there is a whole new level of machine-2-machine remote communciations available for field diagnostics. IMO
No manufacturer is going to produce an elctro-mechanical device without establishing maintenance coverage and a process of elimination for replacement. As part of the engineering design process, design is built in so there are diagnostics to isolate chips, boards and systems for economical replacement. In some cases, those sub-systems are hot-swaped. Meaning if they're not on-site or in the regional area, then they can be overnighted while the defective part is sent back to the factory, or lab for diagnosis.
Congrats. Welcome to the group. The share price has been consolidating in the mid-low $30's for a while. What triggered your decision to invest now?
Hi, thank you for posting this email as a sticky. Can you change the title of the post to read "$.50 options issued to management"? Anyone that's new wouldn't necessarily consider reading the post as its labeled. Thank you.
I have it as a PDF, but can't attach using this board. Where would you like it sent?
That's a good observation. And if any information or updates do start to trickle out - it's all good because that would be net new non-speculative info.
Good morning. Just a brief observation. Not a lot of conversation/chatter but…...The average trading volume has increased >20% over the course of the past month. That's quiet accumulation. Very good for us. MO is that it's due to the news on the patent application for the cancer killing treatment. We're consolidating nicely in the low-mid $.30's and building a solid base for another leg up soon.
To the moderators,
Can someone please sticky Post #809? I think it's very important that this remain in the front of the conversation and information viewed on a daily basis for the near future. Thank you.
Point has been on vacation for the past 2 weeks in NAPA.
Seriously? $.25? Can we please get on with the manipulation so I can buy more and get past all this drivel. I don't think you have the shares to take this much lower.
Those that own shares just have to value what they have and shut off the spigot - which will drive up the ASK price. This could go so much higher on basic IP and general economic elements. Conviction drives a stock price higher as much as anything else.
The good news for you is that we all know that nothing goes up in a straight line. But the price activity has been positive for a little while. Be patient and don't chase. I don't know why I say that - just always keep some powder dry to buy on a dip. GLTU
The good news is that the CEO is very visible, and is working his own brand of PR actively. It will get known soon enough.
L&S TLTFF
AMEN! Someone please put this up on the wall and hang it there for all to read everyday.
Investing; as taught to me by someone with buckets of wisdom, if you know the right questions to ask.
ATTBF at this time has all of the potential that I look for in an infant investment. And here's why.
Even the "best" performing stocks will swing several times per year. The closer a stock is in its infancy the more times it will swing because there are fewer large shareholders, growing and waining conviction, varying interpretations of news, and there's more speculation based on performance.
Compare Abbatis to Gilead. Both in large, expansive and still growing markets. Arguably one of the great biomed stocks of our time. It swings several times a year, yet has the most effective drug since penicillin, with HUGE revenue potential at this time. Notice that word "potential." Its used here because the revenue has not been earned - yet. But the drug exists, the business model exists, the market exists and is growing because diseases don't stop.
You can't buy it below a $1. And when you could - it was 12,000% ago.
Perspective is everything. The Biomed market was in its infancy at one time. How many times in our lifetime will we get to participate in a new market???? This is one - of very few.
My view is that regardless of the economy, and economics do play a big role in market participation, this market will grow in excess of economic performance because of the underlying demand/exposure to the product. Further the "product" has excessive growth potential because it participates in both consumer discressionary and medical applications categories.
Looking for real investments requires cash, vision, a blueprint, a plan of execution, and analytical ability.
Try this perspective and see if it works for you as well as its worked for me.
GLTA
Working with $.10 swings is part of being in this game to buy in at the low end of the share price. For me this is an investment, not a recreational activity.
Who's going to care when it gets over $5.00?
This company is executing very well, and has done everythingthat is necessary to be very successful.
It's in a large demand market - and it's going to grow another 10x or more in the next few years as their technology is applied to the extracts.
Again, this stock will be soooo….. much higher before I retire.
And the licenses are due to arrive sometime this year. Hopefully sooner than later, but patience is required. I don't know anyone that doesn't think that there will be licenses issued. Do you?
And as I said in my previous post. I'm buying and buying some more - because no one can call the bottom. If this stock goes to $.40 then it's only $4,000 for 10,000 shares. Happy, happy, happy.
I'm hoping that this message will put the value of these daily swings in perspective.
In a 10,000 share buy at $.70 (I use that because it's referenced in some emails like it's a ceiling), is $7,000.00
With a $.10 drop you lose a $1,000.00
These stocks swing that much maybe in a week, but everyone knows that about this type of investment. Right?
Now, I've always been taught to dollar cost average my purchases, because no one knows where the bottom is. So if I spend $7,000.00 then I also keep several thousand ready to buy more if it moves below.
These drops are buying opportunities in my mind.
The main event(s) for this company to move forward is to diversify across the industry - and they have.
Establish Strategic Partnerships - and they have.
Build or lease facilities from which to work - and they have.
Next will be the license(s).
The price will go up a lot, before any of us retire.